Is Ameren (AEE) a risky stock?
As of July 21, 2026, Clavix grades Ameren (AEE) B- for risk, a composite score of 68 out of 100 on an A+ to F scale, which puts AEE in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind AEE's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how AEE scores on each, as of July 21, 2026.
What's moving AEE's risk right now
Company-specific signals Clavix flags behind AEE's current grade, drawn from recent news and filings as of July 21, 2026.
Ameren's expected rate hike request, part of its plan to recover capital spending, is meeting political and regulatory pushback. If consumer groups and officials trim the approved increase, Ameren's earnings recovery could slow.
What a B- grade means
On the Clavix A+ to F scale, AEE's composite of 68 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell AEE or any security. Grades are risk indicators, not predictions of return. Data may be delayed.